Search Results
Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer
PARP inhibitors as first-line maintenance therapy in ovarian cancer
Overcoming resistance to PARP inhibition in ovarian cancer
The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP Inhibitors
Comment on SOLO1 for advanced ovarian cancer
Updates in Treatment of Ovarian Cancer: PARP Inhibitors
Can PARP inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 5
Maintenance Therapy in Ovarian Cancer: What You Should Know
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 4
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
Expanding the Benefits of PARP Inhibitors to More Patients With Breast Cancer and Earlier Settings
